48908
Federal
Register
/
Vol.
68,
No.
158
/
Friday,
August
15,
2003
/
Notices
Review
of
EPA
Programs
and
Activities).
Where
a
single
State
or
Territorial
agency
has
been
designated
as
responsible
for
coordinating
lead
activities,
EPA
encourages
that
agency
to
apply
for
funding
under
TSCA
section
404(
g).
Coordination
of
Federally
funded
lead
activities
by
a
single
agency
is
viewed
as
conducive
to
achieving
integration
of
lead
activities.
Early
consultations
are
recommended
between
prospective
applicants
and
their
EPA
Regional
Offices.
Because
TSCA
grants
will
be
administered
at
the
Regional
level,
these
consultations
can
be
critical
to
the
success
of
a
project
or
program,
and
can
also
contribute
substantially
to
efficient
program
operations.
As
part
of
the
work
plan,
EPA
Regional
Offices
may
ask
for
additional
information
that
will
be
useful
in
evaluating
the
program
such
as
the
status
of
enabling
legislation,
a
detailed
line­
item
budget
with
sufficient
information
to
clearly
justify
costs,
a
list
of
work
products
or
deliverables,
a
schedule
for
their
completion
and
application
for
program
authorization
under
TSCA,
and
a
description
of
any
financial
assistance
received
from
other
Federal
sources
concerning
the
lead
program.
Applicants
must
also
include
all
appropriate
information
on
program
income
in
accordance
with
40
CFR
31.25.
Work
plans
are
to
be
negotiated
between
applicants
and
their
Regional
Offices
to
ensure
that
both
EPA
and
State,
Territorial,
or
Tribal
priorities
are
addressed.
Any
application
from
a
State,
Territory,
Indian
Tribe,
or
Intertribal
Consortium
that
is
not
making
sufficient
progress
toward
implementation
of
an
acceptable
program
will
not
be
funded.
Also,
any
applicant
proposing
the
collection
of
environmental
or
health
related
measurements
or
data
generation
must
adequately
address
the
requirements
of
40
CFR
31.45
relating
to
quality
assurance/
quality
control.
EPA
issued
final
guidance
that
provides
details
about
EPA's
requirements
for
the
preparation
of
``
quality
management
plans.''
The
finalized
document
is
titled
``
EPA
Requirements
for
Quality
Management
Plans''
(
EPA
QA/
R
 
2,
March
2001),
and
is
available
from
each
Regional
Office.
8.
Application
procedures.
Applications
must
be
submitted
to
the
appropriate
EPA
Regional
Office
in
duplicate;
one
copy
to
the
Regional
lead
program
branch
and
the
other
to
the
Regional
grants
management
branch.
In
the
case
of
electronic
applications,
if
allowed
by
a
particular
EPA
Regional
Office,
the
applicant
should
follow
the
procedures
required
by
the
Regional
Office
for
submission
of
electronic
applications.
After
the
formula
funding
calculations
are
determined
and
the
funds
are
transferred
to
the
appropriate
EPA
Regional
account,
the
Regional
Office
lead
contact
person
will
contact
the
applicant
and
discuss
the
final
award
allotment.
EPA
Regional
Offices
may
request
the
applicant
to
modify
its
proposed
work
plan
and
cooperative
agreement
based
upon
the
final
cooperative
agreement
allotment.
For
Tribal
applicants,
final
negotiations
for
the
award
of
the
grants,
including
the
completion
of
a
final
work
plan
and
budget,
will
be
completed
after
the
determination
of
successful
applicants.
9.
Reporting.
Pursuant
to
40
CFR
31.40,
grantees
shall,
at
a
minimum,
submit
annual
performance
reports
to
the
appropriate
EPA
Regional
Office.
These
requirements
were
approved
by
the
Office
of
Management
and
Budget
(
OMB)
under
OMB
Control
Number
2030
 
0020
(
General
Administrative
Requirement
for
Assistance
Programs).
The
individual
Regional
Offices
may
require
that
these
reports
be
submitted
on
a
quarterly
or
semiannual
basis,
but
not
more
frequently
than
quarterly.
The
specific
information
contained
within
the
report
will
include,
at
a
minimum,
a
comparison
of
actual
accomplishments
to
the
objectives
established
for
the
period.
Regional
Offices
may
ask
for
the
inclusion
of
specific
data
(
e.
g.,
providing
to
EPA
specific
address
information
associated
with
the
abatement
notifications
that
are
received
by
the
grantee)
as
part
of
the
annual
performance
report
from
the
grantees
which
may
be
useful
for
Agency
reporting
under
the
Government
Performance
and
Results
Act.
It
is
assumed
that
any
data
that
is
requested
to
be
submitted
by
the
grantee
will
already
have
been
collected
pursuant
to
the
grantee's
work
plan.

II.
What
Action
is
the
Agency
Taking?
EPA
is
soliciting
applications
from
States,
Territories,
Indian
Tribes,
Intertribal
Consortia,
and
the
District
of
Columbia
for
financial
assistance
for
purposes
of
developing
and
carrying
out
EPA­
authorized
lead­
based
paint
programs.
Approximately
$
12.5
million
is
available
to
fund
cooperative
agreements
with
States,
Indian
Tribes,
Intertribal
Consortia,
Territories,
and
the
District
of
Columbia
for
development
and
implementation
of
EPA­
authorized
lead­
based
paint
programs.

III.
Statutory
Authority
and
Regulations
EPA
is
authorized
under
TSCA
section
404(
g)
to
make
grants
to
develop
and
carry
out
authorized
lead­
based
paint
programs.
Regulations
governing
these
cooperative
agreements
are
found
at
40
CFR
part
31
and
part
35.

IV.
Submission
to
Congress
and
the
Comptroller
General
Grant
solicitations
such
as
this
are
considered
rules
for
the
purpose
of
the
Congressional
Review
Act
(
CRA).
The
CRA,
5
U.
S.
C.
801
et
seq.,
as
added
by
the
Small
Business
Regulatory
Enforcement
Fairness
Act
of
1996
(
SBREFA),
generally
provides
that,
before
a
rule
may
take
effect,
the
agency
promulgating
the
rule
must
submit
a
rule
report,
which
includes
a
copy
of
the
rule,
to
each
House
of
the
Congress
and
to
the
Comptroller
General
of
the
United
States.
EPA
will
submit
a
report
containing
this
rule
and
other
required
information
to
the
U.
S.
Senate,
the
U.
S.
House
of
Representatives,
and
the
Comptroller
General
of
the
United
States
prior
to
publication
of
the
rule
in
the
Federal
Register.
This
rule
is
not
a
``
major
rule''
as
defined
by
5
U.
S.
C.
804(
2).

V.
Reference
1.
Departments
of
Veterans
Affairs
and
Housing
and
Urban
Development,
and
Independent
Agencies
Appropriations
Act,
Public
Law
105
 
65,
111
Stat.
1374.

List
of
Subjects
Environmental
protection,
Grants,
Lead,
Training
and
accreditation.

Dated:
August
8,
2003.
Susan
B.
Hazen,
Acting
Assistant
Administrator,
Office
of
Prevention,
Pesticides
and
Toxic
Substances.

[
FR
Doc.
03
 
20898
Filed
8
 
14
 
03;
8:
45
am]

BILLING
CODE
6560
 
50
 
S
ENVIRONMENTAL
PROTECTION
AGENCY
[
OPP
 
2003
 
0274;
FRL
 
7322
 
9]

Glufosinate­
Ammonium;
Notice
of
Filing
a
Pesticide
Petition
to
Establish
a
Tolerance
for
a
Certain
Pesticide
Chemical
in
or
on
Food
AGENCY:
Environmental
Protection
Agency
(
EPA).
ACTION:
Notice.

SUMMARY:
This
notice
announces
the
initial
filing
of
a
pesticide
petition
proposing
the
establishment
of
regulations
for
residues
of
a
certain
pesticide
chemical
in
or
on
various
food
commodities.
DATES:
Comments,
identified
by
docket
ID
number
OPP
 
2003
 
0274,
must
be
VerDate
jul<
14>
2003
16:
08
Aug
14,
2003
Jkt
200001
PO
00000
Frm
00033
Fmt
4703
Sfmt
4703
E:\
FR\
FM\
15AUN1.
SGM
15AUN1
48909
Federal
Register
/
Vol.
68,
No.
158
/
Friday,
August
15,
2003
/
Notices
received
on
or
before
September
15,
2003.

ADDRESSES:
Comments
may
be
submitted
electronically,
by
mail,
or
through
hand
delivery/
courier.
Follow
the
detailed
instructions
as
provided
in
Unit
I.
of
the
SUPPLEMENTARY
INFORMATION.

FOR
FURTHER
INFORMATION
CONTACT:
Joanne
I.
Miller,
Registration
Division
(
7505C),
Office
of
Pesticide
Programs,
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460
 
0001;
telephone
number:
(
703)
305
 
6224;
e­
mail
address:
miller.
joanne@
epa.
gov.

SUPPLEMENTARY
INFORMATION:

I.
General
Information
A.
Does
This
Action
Apply
to
Me?

You
may
be
potentially
affected
by
this
action
if
you
are
an
agricultural
producer,
food
manufacturer,
or
pesticide
manufacturer.
Potentially
affected
entities
may
include,
but
are
not
limited
to:
 
Crop
production
(
NAICS
111)
 
Animal
production
(
NAICS
112)
 
Food
manufacturing
(
NAICS
311)
 
Pesticide
manufacturing
(
NAICS
32532)
This
listing
is
not
intended
to
be
exhaustive,
but
rather
provides
a
guide
for
readers
regarding
entities
likely
to
be
affected
by
this
action.
Other
types
of
entities
not
listed
in
this
unit
could
also
be
affected.
The
North
American
Industrial
Classification
System
(
NAICS)
codes
have
been
provided
to
assist
you
and
others
in
determining
whether
this
action
might
apply
to
certain
entities.
If
you
have
any
questions
regarding
the
applicability
of
this
action
to
a
particular
entity,
consult
the
person
listed
under
FOR
FURTHER
INFORMATION
CONTACT.

B.
How
Can
I
Get
Copies
of
This
Document
and
Other
Related
Information?

1.
Docket.
EPA
has
established
an
official
public
docket
for
this
action
under
docket
identification
(
ID)
number
OPP
 
2003
 
0274.
The
official
public
docket
consists
of
the
documents
specifically
referenced
in
this
action,
any
public
comments
received,
and
other
information
related
to
this
action.
Although
a
part
of
the
official
docket,
the
public
docket
does
not
include
Confidential
Business
Information
(
CBI)
or
other
information
whose
disclosure
is
restricted
by
statute.
The
official
public
docket
is
the
collection
of
materials
that
is
available
for
public
viewing
at
the
Public
Information
and
Records
Integrity
Branch
(
PIRIB),
Rm.
119,
Crystal
Mall
#
2,
1921
Jefferson
Davis
Hwy.,
Arlington,
VA.
This
docket
facility
is
open
from
8:
30
a.
m.
to
4
p.
m.,
Monday
through
Friday,
excluding
legal
holidays.
The
docket
telephone
number
is
(
703)
305
 
5805.
2.
Electronic
access.
You
may
access
this
Federal
Register
document
electronically
through
the
EPA
Internet
under
the
``
Federal
Register''
listings
at
http://
www.
epa.
gov/
fedrgstr/.
An
electronic
version
of
the
public
docket
is
available
through
EPA's
electronic
public
docket
and
comment
system,
EPA
Dockets.
You
may
use
EPA
Dockets
at
http://
www.
epa.
gov/
edocket/
to
submit
or
view
public
comments,
access
the
index
listing
of
the
contents
of
the
official
public
docket,
and
to
access
those
documents
in
the
public
docket
that
are
available
electronically.
Although
not
all
docket
materials
may
be
available
electronically,
you
may
still
access
any
of
the
publicly
available
docket
materials
through
the
docket
facility
identified
in
Unit
I.
B.
1.
Once
in
the
system,
select
``
search,''
then
key
in
the
appropriate
docket
ID
number.
Certain
types
of
information
will
not
be
placed
in
the
EPA
Dockets.
Information
claimed
as
CBI
and
other
information
whose
disclosure
is
restricted
by
statute,
which
is
not
included
in
the
official
public
docket,
will
not
be
available
for
public
viewing
in
EPA's
electronic
public
docket.
EPA's
policy
is
that
copyrighted
material
will
not
be
placed
in
EPA's
electronic
public
docket
but
will
be
available
only
in
printed,
paper
form
in
the
official
public
docket.
To
the
extent
feasible,
publicly
available
docket
materials
will
be
made
available
in
EPA's
electronic
public
docket.
When
a
document
is
selected
from
the
index
list
in
EPA
Dockets,
the
system
will
identify
whether
the
document
is
available
for
viewing
in
EPA's
electronic
public
docket.
Although
not
all
docket
materials
may
be
available
electronically,
you
may
still
access
any
of
the
publicly
available
docket
materials
through
the
docket
facility
identified
in
Unit
I.
B.
EPA
intends
to
work
towards
providing
electronic
access
to
all
of
the
publicly
available
docket
materials
through
EPA's
electronic
public
docket.
For
public
commenters,
it
is
important
to
note
that
EPA's
policy
is
that
public
comments,
whether
submitted
electronically
or
in
paper,
will
be
made
available
for
public
viewing
in
EPA's
electronic
public
docket
as
EPA
receives
them
and
without
change,
unless
the
comment
contains
copyrighted
material,
CBI,
or
other
information
whose
disclosure
is
restricted
by
statute.
When
EPA
identifies
a
comment
containing
copyrighted
material,
EPA
will
provide
a
reference
to
that
material
in
the
version
of
the
comment
that
is
placed
in
EPA's
electronic
public
docket.
The
entire
printed
comment,
including
the
copyrighted
material,
will
be
available
in
the
public
docket.
Public
comments
submitted
on
computer
disks
that
are
mailed
or
delivered
to
the
docket
will
be
transferred
to
EPA's
electronic
public
docket.
Public
comments
that
are
mailed
or
delivered
to
the
docket
will
be
scanned
and
placed
in
EPA's
electronic
public
docket.
Where
practical,
physical
objects
will
be
photographed,
and
the
photograph
will
be
placed
in
EPA's
electronic
public
docket
along
with
a
brief
description
written
by
the
docket
staff.

C.
How
and
To
Whom
Do
I
Submit
Comments?

You
may
submit
comments
electronically,
by
mail,
or
through
hand
delivery/
courier.
To
ensure
proper
receipt
by
EPA,
identify
the
appropriate
docket
ID
number
in
the
subject
line
on
the
first
page
of
your
comment.
Please
ensure
that
your
comments
are
submitted
within
the
specified
comment
period.
Comments
received
after
the
close
of
the
comment
period
will
be
marked
``
late.''
EPA
is
not
required
to
consider
these
late
comments.
If
you
wish
to
submit
CBI
or
information
that
is
otherwise
protected
by
statute,
please
follow
the
instructions
in
Unit
I.
D.
Do
not
use
EPA
Dockets
or
e­
mail
to
submit
CBI
or
information
protected
by
statute.
1.
Electronically.
If
you
submit
an
electronic
comment
as
prescribed
in
this
unit,
EPA
recommends
that
you
include
your
name,
mailing
address,
and
an
email
address
or
other
contact
information
in
the
body
of
your
comment.
Also
include
this
contact
information
on
the
outside
of
any
disk
or
CD
ROM
you
submit,
and
in
any
cover
letter
accompanying
the
disk
or
CD
ROM.
This
ensures
that
you
can
be
identified
as
the
submitter
of
the
comment
and
allows
EPA
to
contact
you
in
case
EPA
cannot
read
your
comment
due
to
technical
difficulties
or
needs
further
information
on
the
substance
of
your
comment.
EPA's
policy
is
that
EPA
will
not
edit
your
comment,
and
any
identifying
or
contact
information
provided
in
the
body
of
a
comment
will
be
included
as
part
of
the
comment
that
is
placed
in
the
official
public
docket,
and
made
available
in
EPA's
electronic
public
docket.
If
EPA
cannot
read
your
comment
due
to
technical
difficulties
and
cannot
contact
you
for
clarification,
EPA
may
not
be
able
to
consider
your
comment.

VerDate
jul<
14>
2003
16:
08
Aug
14,
2003
Jkt
200001
PO
00000
Frm
00034
Fmt
4703
Sfmt
4703
E:\
FR\
FM\
15AUN1.
SGM
15AUN1
48910
Federal
Register
/
Vol.
68,
No.
158
/
Friday,
August
15,
2003
/
Notices
i.
EPA
Dockets.
Your
use
of
EPA's
electronic
public
docket
to
submit
comments
to
EPA
electronically
is
EPA's
preferred
method
for
receiving
comments.
Go
directly
to
EPA
Dockets
at
http://
www.
epa.
gov/
edocket,
and
follow
the
online
instructions
for
submitting
comments.
Once
in
the
system,
select
``
search,''
and
then
key
in
docket
ID
number
OPP
 
2003
 
0274.
The
system
is
an
``
anonymous
access''
system,
which
means
EPA
will
not
know
your
identity,
e­
mail
address,
or
other
contact
information
unless
you
provide
it
in
the
body
of
your
comment.
ii.
E­
mail.
Comments
may
be
sent
by
e­
mail
to
opp­
docket@
epa.
gov,
Attention:
Docket
ID
Number
OPP
 
2003
 
0274.
In
contrast
to
EPA's
electronic
public
docket,
EPA's
e­
mail
system
is
not
an
``
anonymous
access''
system.
If
you
send
an
e­
mail
comment
directly
to
the
docket
without
going
through
EPA's
electronic
public
docket,
EPA's
e­
mail
system
automatically
captures
your
e­
mail
address.
E­
mail
addresses
that
are
automatically
captured
by
EPA's
e­
mail
system
are
included
as
part
of
the
comment
that
is
placed
in
the
official
public
docket,
and
made
available
in
EPA's
electronic
public
docket.
iii.
Disk
or
CD
ROM.
You
may
submit
comments
on
a
disk
or
CD
ROM
that
you
mail
to
the
mailing
address
identified
in
Unit
I.
C.
2.
These
electronic
submissions
will
be
accepted
in
WordPerfect
or
ASCII
file
format.
Avoid
the
use
of
special
characters
and
any
form
of
encryption.
2.
By
mail.
Send
your
comments
to:
Public
Information
and
Records
Integrity
Branch
(
PIRIB)
(
7502C),
Office
of
Pesticide
Programs
(
OPP),
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460
 
0001,
Attention:
Docket
ID
Number
OPP
 
2003
 
0274.
3.
By
hand
delivery
or
courier.
Deliver
your
comments
to:
Public
Information
and
Records
Integrity
Branch
(
PIRIB),
Office
of
Pesticide
Programs
(
OPP),
Environmental
Protection
Agency,
Rm.
119,
Crystal
Mall
#
2,
1921
Jefferson
Davis
Hwy.,
Arlington,
VA,
Attention:
Docket
ID
Number
OPP
 
2003
 
0274.
Such
deliveries
are
only
accepted
during
the
docket's
normal
hours
of
operation
as
identified
in
Unit
I.
B.
1.

D.
How
Should
I
Submit
CBI
to
the
Agency?
Do
not
submit
information
that
you
consider
to
be
CBI
electronically
through
EPA's
electronic
public
docket
or
by
e­
mail.
You
may
claim
information
that
you
submit
to
EPA
as
CBI
by
marking
any
part
or
all
of
that
information
as
CBI
(
if
you
submit
CBI
on
disk
or
CD
ROM,
mark
the
outside
of
the
disk
or
CD
ROM
as
CBI
and
then
identify
electronically
within
the
disk
or
CD
ROM
the
specific
information
that
is
CBI).
Information
so
marked
will
not
be
disclosed
except
in
accordance
with
procedures
set
forth
in
40
CFR
part
2.
In
addition
to
one
complete
version
of
the
comment
that
includes
any
information
claimed
as
CBI,
a
copy
of
the
comment
that
does
not
contain
the
information
claimed
as
CBI
must
be
submitted
for
inclusion
in
the
public
docket
and
EPA's
electronic
public
docket.
If
you
submit
the
copy
that
does
not
contain
CBI
on
disk
or
CD
ROM,
mark
the
outside
of
the
disk
or
CD
ROM
clearly
that
it
does
not
contain
CBI.
Information
not
marked
as
CBI
will
be
included
in
the
public
docket
and
EPA's
electronic
public
docket
without
prior
notice.
If
you
have
any
questions
about
CBI
or
the
procedures
for
claiming
CBI,
please
consult
the
person
listed
under
FOR
FURTHER
INFORMATION
CONTACT.

E.
What
Should
I
Consider
as
I
Prepare
My
Comments
for
EPA?

You
may
find
the
following
suggestions
helpful
for
preparing
your
comments:
1.
Explain
your
views
as
clearly
as
possible.
2.
Describe
any
assumptions
that
you
used.
3.
Provide
copies
of
any
technical
information
and/
or
data
you
used
that
support
your
views.
4.
If
you
estimate
potential
burden
or
costs,
explain
how
you
arrived
at
the
estimate
that
you
provide.
5.
Provide
specific
examples
to
illustrate
your
concerns.
6.
Make
sure
to
submit
your
comments
by
the
deadline
in
this
notice.
7.
To
ensure
proper
receipt
by
EPA,
be
sure
to
identify
the
docket
ID
number
assigned
to
this
action
in
the
subject
line
on
the
first
page
of
your
response.
You
may
also
provide
the
name,
date,
and
Federal
Register
citation.

II.
What
Action
is
the
Agency
Taking?

EPA
has
received
a
pesticide
petition
as
follows
proposing
the
establishment
and/
or
amendment
of
regulations
for
residues
of
a
certain
pesticide
chemical
in
or
on
various
food
commodities
under
section
408
of
the
Federal
Food,
Drug,
and
Cosmetic
Act
(
FFDCA),
21
U.
S.
C.
346a.
EPA
has
determined
that
this
petition
contains
data
or
information
regarding
the
elements
set
forth
in
FFDCA
section
408(
d)(
2);
however,
EPA
has
not
fully
evaluated
the
sufficiency
of
the
submitted
data
at
this
time
or
whether
the
data
support
granting
of
the
petition.
Additional
data
may
be
needed
before
EPA
rules
on
the
petition.

List
of
Subjects
Environmental
protection,
Agricultural
commodities,
Feed
additives,
Food
additives,
Pesticides
and
pests,
Reporting
and
recordkeeping
requirements.

Dated:
August
11,
2003.
Peter
Caulkins,
Acting
Director,
Registration
Division,
Office
of
Pesticide
Programs.

Summary
of
Petition
The
petitioner
summary
of
the
pesticide
petition
is
printed
below
as
required
by
FFDCA
section
408(
d)(
3).
The
summary
of
the
petition
was
prepared
by
the
petitioner
and
represents
the
view
of
the
petitioner.
The
petition
summary
announces
the
availability
of
a
description
of
the
analytical
methods
available
to
EPA
for
the
detection
and
measurement
of
the
pesticide
chemical
residues
or
an
explanation
of
why
no
such
method
is
needed.

Bayer
CropScience
PP
0F06140
and
PP
0F06210
EPA
has
received
pesticide
petitions
(
PP
0F06140
and
0F06210)
from
Bayer
CropScience,
2
T.
W.
Alexander
Drive,
Research
Triangle
Park,
NC
27709
proposing,
pursuant
to
section
408(
d)
of
the
Federal
Food,
Drug,
and
Cosmetic
Act
(
FFDCA),
21
U.
S.
C.
346a(
d),
to
amend
40
CFR
180.473
by
establishing
a
tolerance
for
residues
of
the
herbicide
glufosinate­
ammonium
(
butanoic
acid,
2­
amino­
4­(
hydroxymethylphosphinyl)­,
monoammonium
salt)
and
its
metabolite,
3­
methylphosphinicopropionic
acid
expressed
as
2­
amino­
4­
(
hydroxymethylphosphinyl)
butanoic
acid
equivalents
in
or
on
the
raw
agricultural
commodities:
Cotton,
undelinted
seed
at
4.0
parts
per
million
(
ppm);
cotton
gin
byproducts
at
15
ppm;
cattle,
fat
at
0.4
ppm;
cattle,
meat
at
0.15
ppm;
cattle
meat
byproducts
at
6.0
ppm;
goat,
fat
at
0.4
ppm;
goat,
meat
at
0.15
ppm;
goat
meat
byproducts
at
6.0
ppm;
hog,
fat
at
0.4
ppm;
hog,
meat
at
0.15
ppm;
hog
meat
byproducts
at
6.0
ppm;
horse,
fat
at
0.4
ppm;
horse,
meat
at
0.15
ppm;
horse
meat
byproducts
at
6.0
ppm;
sheep,
fat
at
0.4
ppm;
sheep,
meat
at
0.15
ppm;
sheep
meat
byproducts
at
6.0
ppm;
egg
at
0.15
ppm;
milk
at
0.15
ppm;
poultry,
fat
at
0.15
ppm;
poultry,
meat
at
0.15
ppm;
and
poultry
meat
byproducts
at
0.6
ppm.
Bayer
CropScience
also
proposes
establishing
a
tolerance
for
residues
of
the
herbicide
glufosinate­
ammonium
(
butanoic
acid,

VerDate
jul<
14>
2003
16:
08
Aug
14,
2003
Jkt
200001
PO
00000
Frm
00035
Fmt
4703
Sfmt
4703
E:\
FR\
FM\
15AUN1.
SGM
15AUN1
48911
Federal
Register
/
Vol.
68,
No.
158
/
Friday,
August
15,
2003
/
Notices
2­
amino­
4­(
hydroxymethylphosphinyl)­,
monoammonium
salt)
and
its
metabolites,
3­
methylphosphinicopropionic
acid,
and
2­
acetamido­
4­
methylphosphinicobutanoic
acid
expressed
as
2­
amino­
4­
(
hydroxymethylphosphinyl)
butanoic
acid
equivalents
in
or
on
the
raw
agricultural
commodities
derived
from
transgenic
cotton
and
rice
tolerant
to
glufosinate­
ammonium:
Rice,
grain
at
1.0
ppm;
rice,
straw
at
2.0
ppm;
rice,
hull
at
2.0
ppm;
cotton,
undelinted
seed
at
4.0
ppm;
and
cotton,
gin
byproducts
at
15.0
ppm.
EPA
has
determined
that
the
petition
contains
data
or
information
regarding
the
elements
set
forth
in
section
408(
d)(
2)
of
the
FFDCA;
however,
EPA
has
not
fully
evaluated
the
sufficiency
of
the
submitted
data
at
this
time
or
whether
the
data
supports
granting
of
the
petition.
Additional
data
may
be
needed
before
EPA
rules
on
the
petition.

A.
Residue
Chemistry
1.
Plant
metabolism.
Metabolism
studies
have
been
conducted
on
crops
tolerant
to
glufosinate­
ammonium
using
radiolabeled
parent.
As
a
result,
the
nature
of
residues
found
in
cotton,
rice,
and
other
transgenic
crops
tolerant
to
glufosinate
ammonium
is
well
understood.
The
principal
residue
in
raw
agricultural
commodities
at
harvest
was
3­
methylphosphinicopropionic
acid
(
Hoe
061517).
Other
relevant
residues
are
N­
acetyl­
L­
glufosinate
(
2­
acetamido­
4­
methylphosphinico­
butanoic
acid,
Hoe
099730)
and
lesser
amounts
of
the
parent
compound.
2.
Analytical
method.
The
enforcement
analytical
method
utilizes
gas
chromatography
for
detecting
and
measuring
levels
of
glufosinateammonium
and
metabolites
with
a
general
limit
of
quantification
of
0.05
ppm.
This
method
allows
detection
of
residues
at
or
above
the
proposed
tolerances.
3.
Magnitude
of
residues.
Field
residue
trials
were
conducted
across
the
major
regions
of
rice
and
cotton
production
in
the
United
States.
The
treatment
regime
was
selected
to
represent
the
use
pattern
that
is
the
most
likely
to
result
in
the
highest
residues.
When
sampled
at
70
days
or
more
after
the
last
application
glufosinate­
ammonium
derived
residues
did
not
exceed
0.74
ppm
in
rice
grain
and
1.48
ppm
in
rice
straw;
whereas,
in
cotton
seed
and
gin
by
products
the
highest
mean
residue
level
was
3.2
ppm
and
10.58
ppm,
respectively.
No
concentration
of
the
residues
occurred
when
rice
whole
grain
was
processed
into
polished
grain
and
bran,
whereas
a
concentration
factor
of
approximately
2.3
was
found
for
rice
hulls.
After
ginning,
the
cotton
seed
was
processed
into
meal,
hulls,
and
refined
oil.
No
concentration
of
the
residues
upon
processing
of
the
cotton
seed
was
observed.

B.
Toxicological
Profile
1.
Acute
toxicity.
Glufosinateammonium
has
been
classified
as
toxicity
category
III
for
acute
oral,
dermal,
and
inhalation
toxicity;
and
for
eye
irritation.
Glufosinate­
ammonium
is
not
a
dermal
irritant
(
toxicity
category
IV)
nor
is
it
a
dermal
sensitizer.
The
oral
LD50
is
2,000
milligrams/
kilogram
(
mg/
kg)
in
male
rats
and
1,620
mg/
kg
in
female
rats.
2.
Genotoxicity.
Based
on
results
of
a
complete
genotoxicity
data
base,
there
is
no
evidence
of
mutagenic
activity
in
a
battery
of
studies,
including:
Salmonella
spp.,
E.
coli,
in
vitro
mammalian
cell
gene
mutation
assays,
mammalian
cell
chromosome
aberration
assays,
in
vivo
mouse
bone
marrow
micronucleus
assays,
and
unscheduled
DNA
synthesis
assays.
3.
Reproductive
and
developmental
toxicity.
In
a
developmental
toxicity
study,
groups
of
20
pregnant
female
Wistar
rats
were
administered
glufosinate­
ammonium
by
gavage
at
doses
of
0,
0.5,
2.24
10,
50,
and
250
mg/
kg/
day
from
days
7
to
16
of
pregnancy.
The
no
observed
adverse
effect
level
(
NOAEL)
for
maternal
toxicity
is
10
mg/
kg/
day;
the
lowest
observed
adverse
effect
level
(
LOAEL)
is
50
mg/
kg/
day
based
on
vaginal
bleeding
and
hyperactivity
in
dams.
In
the
fetus,
the
NOAEL
is
50
mg/
kg/
day,
based
on
dilated
renal
pelvis
observations
at
the
LOAEL
of
250
mg/
kg/
day.
In
a
developmental
toxicity
study,
groups
of
15
pregnant
female
Himalayan
rabbits
were
administered
glufosinateammonium
by
gavage
at
doses
of
0,
2.0,
6.3,
or
20.0
mg/
kg/
day
from
days
7
to
19
of
pregnancy.
In
maternal
animals,
decreases
in
food
consumption
and
body
weight
gain
were
observed
at
the
20
mg/
kg/
day
dose
level.
The
NOAEL
for
maternal
toxicity
was
6.3
mg/
kg/
day
and
that
for
developmental
toxicity
was
20
mg/
kg/
day.
In
a
multi­
generation
reproduction
study,
glufosinate­
ammonium
was
administered
to
groups
of
30
male
and
30
female
Wistar/
Han
rats
in
the
diet
at
concentrations
of
0,
40,
120,
or
360
ppm.
The
LOAEL
for
systemic
toxicity
is
120
ppm
based
on
increased
kidney
weights
in
both
sexes
and
generations.
The
systemic
toxicity
NOAEL
is
40
ppm.
The
LOAEL
for
reproductive/
developmental
toxicity
is
360
ppm
based
on
decreased
numbers
of
viable
pups
in
all
generations.
The
NOAEL
is
120
ppm.
4.
Subchronic
toxicity.
In
a
subchronic
oral
toxicity
study,
glufosinateammonium
was
administered
to
10
NMRI
mice/
sex/
dose
in
the
diet
at
levels
of
0,
80,
320,
or
1,280
ppm
(
equivalent
to
0,
12,
48,
or
192
millgrams/
kilogram/
day
(
mg/
kg/
day))
for
13
weeks.
Significant
(
p<
0.05)
increases
were
observed
in
serum
aspartate
aminotransferase
and
in
alkaline
phosphatase
in
high­
dose
(
192
mg/
kg/
day)
males.
Also
observed
were
increases
in
absolute
and
relative
liver
weights
in
mid­(
48
mg/
kg/
day)
and
high­
dose
males.
The
NOAEL
is
12
mg/
kg/
day,
the
LOAEL
is
48
mg/
kg/
day
based
on
the
changes
in
clinical
biochemistry
and
liver
weights.
5.
Chronic
toxicity.
In
a
combined
chronic
toxicity/
oncogenicity
study,
glufosinate­
ammonium
was
administered
to
50
Wistar
rats/
sex/
dose
in
the
diet
for
130
weeks
at
dose
levels
of
0,
40,
140,
or
500
ppm
(
mean
compound
intake
in
males
was
0,
1.9,
6.8,
and
24.4
mg/
kg/
day
and
for
females
was
0,
2.4,
8.2,
and
28.7
mg/
kg/
day,
respectively).
A
dose­
related
increase
in
mortality
was
noted
in
females
at
140
and
500
ppm,
whereas
in
males
increased
absolute
and
relative
kidney
weights
were
noted
at
140
ppm
and
500
ppm.
The
NOAEL
was
considered
to
be
40
ppm.
No
treatment­
related
oncogenic
response
was
noted.
In
an
oncogenicity
study,
glufosinateammonium
was
administered
to
50
NMRI
mice/
sex/
dose
in
the
diet
at
dose
levels
of
0,
80,
160
(
males
only)
or
320
(
females
only)
ppm
for
104
weeks.
The
NOAEL
for
systemic
toxicity
is
80
ppm
(
10.82/
16.19
mg/
kg/
day
in
males/
females
(
M/
F)),
and
the
LOAEL
is
160/
320
ppm
(
22.60/
63.96
mg/
kg/
day
in
M/
F),
based
on
increased
mortality
in
males,
increased
glucose
levels
in
males
and
females,
and
changes
in
glutathione
levels
in
males.
No
increase
in
tumor
incidence
was
found
in
any
treatment
group.
In
a
chronic
feeding
study,
technical
glufosinate­
ammonium
was
fed
to
male
and
female
beagle
dogs
for
12
months
in
the
diet
at
levels
of
2.0,
5.0,
or
8.5
mg/
kg/
day.
The
NOAEL
is
5.0
mg/
kg/
day
based
on
clinical
signs
of
toxicity,
reduced
weight
gain
and
mortality
8.5
mg/
kg/
day.
In
a
rat
oncogenicity
study,
glufosinate­
ammonium
was
administered
to
Wistar
rats
(
60/
sex/
group)
for
up
to
24
months
at
0,
1,000,
5,000,
or
10,000
ppm
(
equivalent
to
0,
45.4,
228.9,
or
466.3
mg/
kg/
day
in
males
and
0,
57.1,
281.5,
or
579.3
mg/
kg/
day
in
females).
The
LOAEL
for
chronic
toxicity
is
5,000
ppm
(
equivalent
to
VerDate
jul<
14>
2003
16:
08
Aug
14,
2003
Jkt
200001
PO
00000
Frm
00036
Fmt
4703
Sfmt
4703
E:\
FR\
FM\
15AUN1.
SGM
15AUN1
48912
Federal
Register
/
Vol.
68,
No.
158
/
Friday,
August
15,
2003
/
Notices
228.9
mg/
kg/
day
for
male
rats
and
281.5
mg/
kg/
day
for
females),
based
on
increased
incidences
of
retinal
atrophy.
The
chronic
NOAEL
is
1,000
ppm.
Under
the
conditions
of
this
study,
there
was
no
evidence
of
carcinogenic
potential.
Dosing
was
considered
adequate
based
on
the
increased
incidence
of
retinal
atrophy.
6.
Animal
metabolism.
Studies
conducted
in
rats
using
14C­
glufosinateammonium
have
shown
that
the
compound
is
poorly
absorbed
(
5­
10%)
after
oral
administration
and
is
rapidly
eliminated
primarily
as
the
parent
compound.
The
highest
residue
levels
were
found
in
liver
and
kidney
tissues.
The
metabolic
profile
and
the
quantitative
distribution
of
metabolites
were
very
similar
in
both
goat
and
hen.
The
vast
majority
of
the
dose
was
excreted,
primarily
as
parent
compound.
The
very
limited
residues
found
in
edible
tissues,
milk
and
eggs
were
comprised
principally
of
glufosinate
and
3­
methylphosphinicopropionic
acid
(
Hoe
061517),
with
lesser
amounts
of
N­
acetyl­
L­
glufosinate
(
Hoe
099730)
and
2­
methylohosphinicoacetic
acid
(
Hoe
064619).
7.
Metabolite
toxicology.
Additional
testing
has
been
conducted
with
the
major
metabolites,
3­
methylphosphinico­
propionic
acid,
and
N­
acetyl­
L­
glufosinate.
Based
on
subchronic
and
developmental
toxicity
study
results,
a
profile
of
similar
or
less
toxicity
was
observed
for
the
metabolites
as
compared
to
the
parent
compound,
glufosinate­
ammonium.
8.
Endocrine
disruption.
No
special
studies
have
been
conducted
to
investigate
the
potential
of
glufosinateammonium
to
induce
estrogenic
or
other
endocrine
effects.
However,
no
evidence
of
estrogenic
or
other
endocrine
effects
have
been
noted
in
any
of
the
toxicology
studies
that
have
been
conducted
with
this
product
and
there
is
no
reason
to
suspect
that
any
such
effects
would
be
likely.

C.
Aggregate
Exposure
1.
Dietary
exposure.
Tolerances
have
been
established
(
40
CFR
180.473)
for
the
combined
residues
of
glufosinateammonium
and
metabolites
in
or
on
a
variety
of
raw
agricultural
commodities.
No
appropriate
toxicological
endpoint
attributable
to
a
single
exposure
was
identified
in
the
available
toxicity
studies.
EPA
has,
therefore,
not
established
an
acute
reference
dose
(
RfD)
for
the
general
population
including
infants
and
children.
An
acute
population
adjusted
dose
(
aPAD
­
95th
percentile)
of
0.021
mg/
kg/
day
was
established,
however,
for
the
females
13+
subgroup
based
on
the
results
of
the
developmental
toxicity
study
in
rabbits
with
an
uncertainty
factor
of
300.
Therefore,
an
acute
dietary
analysis
was
conducted
for
this
sub­
population;
whereas,
chronic
dietary
analysis
was
conducted
for
the
usual
populations.
A
chronic
population
adjusted
dose
(
cPAD)
of
0.007
mg/
kg/
day
(
based
on
the
2
 
year
chronic
study
in
rats
and
an
uncertainty
factor
of
300)
was
used
to
perform
the
chronic
dietary
analysis.
i.
Food.
An
acute
dietary
analysis
was
conducted
using
the
Dietary
Exposure
Evaluation
Model
(
DEEMTM)
software
version
7.6
and
the
1994
 
1998
Continuing
Survey
of
Food
Intake
by
Individuals
(
CSFII)
consumption
data
base.
The
Tier
I
acute
dietary
assessment
was
modified
by
incorporating
percent
crop
treated
(
PCT)
values
for
blended
items
only.
Thus,
the
following
PCT
values
were
used:
Soybean,
6%;
canola,
11%;
cotton,
15%,
rice,
2%;
sugar
beet,
1%;
and
sugar
beet
molasses,
1%.
Tolerance
values
of
blended
feed
items
in
the
animal
diets
were
also
multiplied
by
PCT.
Dietary
burdens
were
then
multiplied
by
the
maximum
tissue
to
feed
ratios
observed
in
the
animal
feeding
studies.
This
Tier
I
analysis
resulted
in
an
exposure
of
0.002746
mg/
kg
bw/
day
(
95th
percentile)
for
the
female
13+
subpopulation
(
the
only
population
of
concern)
representing
13%
utilization
of
the
aPAD.
Chronic
dietary
analysis
was
conducted
to
estimate
exposure
to
potential
glufosinate­
ammonium
residues
in
or
on
registered
and
proposed
commodities.
The
DEEMTM
software
(
version
7.6)
and
the
1994
 
1998
USDA
food
consumption
data
were
used.
Tolerance
level
residues
were
assumed
for
all
commodities.
Percent
crop
treated
values
generated
by
EPA/
BEAD
and
Bayer
CropScience
were
incorporated
as
follows:
Tree
nuts,
1%;
apples,
1%;
field
corn,
3%;
grapes,
1%;
soybeans,
6%;
potatoes,
1%;
canola,
11%;
and
sugar
beet,
1%.
Bayer
CropScience
estimates
that
an
upper
bound
value
for
cotton
at
market
maturity
is
15%
and
that
for
rice
is
2%.
All
other
crops
are
included
at
100%
of
crop
treated.
For
the
chronic
dietary
risk
assessment,
secondary
residues
that
could
occur
as
a
result
of
residues
of
glufosinate­
ammonium
and
metabolites
in
the
diet
of
ruminants
and
poultry
were
adjusted
for
percent
of
the
crop
treated
as
indicated
above.
Chronic
dietary
exposure
estimates
from
residues
of
glufosinate­
ammonium
for
the
U.
S.
population
represented
approximately
3.2%
of
the
chronic
PAD;
whereas
that
for
children
1­
2,
the
subpopulation
with
the
highest
exposure,
represented
approximately
12%
of
the
chronic
PAD.
The
approach
used
is
very
conservative,
yet
still
indicates
that
dietary
exposures
for
all
segments
of
the
population
are
well
within
the
chronic
reference
doses.
This
analysis
was
based
on
highly
conservative
assumptions.
The
Agency
has
no
concerns
with
PAD
utilization
up
to
100%.
ii.
Drinking
water.
U.
S.
EPA's
Standard
Operating
Procedure
(
SOP)
for
Drinking
Water
Exposure
and
Risk
Assessments
was
used
to
perform
the
drinking
water
assessment.
The
models
Screening
Concentrations
in
Ground
Water
(
SCI­
GROW)
and
EPA's
Pesticide
Root
Zone
Model/
Exposure
Analysis
Modeling
System
(
PRZM/
EXAMS)
were
used
to
estimate
the
concentration
of
glufosinate­
ammonium
that
might
occur
in
water.
The
acute
drinking
water
level
of
comparison
(
DWLOC)
for
females
13+
is
548
parts
per
billion
(
ppb).
In
comparison,
the
acute
estimated
drinking
water
concentrations
(
EDWC)
calculated
by
PRZM/
EXAMS
is
67
ppb.
The
chronic
DWLOC
calculated
for
adults
is
237
ppb
and
that
for
children/
toddlers
is
62
ppb.
The
chronic
EDWC
calculated
using
a
worst
case
scenario
is
17
ppb
PRZM/
EXAMS.
The
DWLOCs
are
based
on
highly
conservative
dietary
(
food)
exposures
and
are
expected
to
be
much
higher
in
real
world
situations
reducing
further
the
percent
utilization
of
the
DWLOC.
2.
Non­
dietary
exposure.
U.
S.
EPA's
SOP
for
Drinking
Water
Exposure
and
Risk
Assessments
was
used
to
perform
the
drinking
water
assessment.
The
models
SCI­
GROW
and
PRZM/
EXAMS
were
used
to
estimate
the
concentration
of
glufosinate­
ammonium
that
might
occur
in
water.
The
acute
DWLOC
for
females
13+
is
548
ppb.
In
comparison,
the
acute
EDWC
calculated
by
PRZM/
EXAMS
is
67
ppb.
The
chronic
DWLOC
calculated
for
adults
is
237
ppb
and
that
for
children/
toddlers
is
62
ppb.
The
chronic
EDWC
calculated
using
a
worst
case
scenario
is
17
ppb
PRZM/
EXAMS.
The
DWLOCs
are
based
on
highly
conservative
dietary
(
food)
exposures
and
are
expected
to
be
much
higher
in
real
world
situations
reducing
further
the
percent
utilization
of
the
DWLOC.

D.
Cumulative
Effects
Section
408(
b)(
2)(
D)(
v)
requires
that,
when
considering
whether
to
establish,
modify,
or
revoke
a
tolerance,
the
Agency
consider
``
available
information''
concerning
the
cumulative
effects
of
a
particular
pesticide's
residues
and
``
other
substances
that
have
a
common
mechanism
of
toxicity.''
EPA
has
indicated
that,
at
this
time,
the
Agency
does
not
have
available
data
to
determine
whether
glufosinate­

VerDate
jul<
14>
2003
16:
08
Aug
14,
2003
Jkt
200001
PO
00000
Frm
00037
Fmt
4703
Sfmt
4703
E:\
FR\
FM\
15AUN1.
SGM
15AUN1
48913
Federal
Register
/
Vol.
68,
No.
158
/
Friday,
August
15,
2003
/
Notices
ammonium
has
a
common
mechanism
of
toxicity
with
other
substances
or
how
to
include
this
pesticide
in
a
cumulative
risk
assessment.
Unlike
other
pesticides
for
which
EPA
has
followed
a
cumulative
risk
approach
based
on
a
common
mechanism
of
toxicity,
glufosinate­
ammonium
does
not
appear
to
produce
a
toxic
metabolite
produced
by
other
substances.
For
the
purposes
of
this
tolerance
petition,
therefore,
it
has
not
been
assumed
that
glufosinateammonium
has
a
common
mechanism
of
toxicity
with
other
substances.

E.
Safety
Determination
1.
U.
S.
population.
Using
the
conservative
assumptions
described
above
and
based
on
the
completeness
and
reliability
of
the
toxicity
data,
it
is
concluded
that
chronic
dietary
exposure
to
the
registered
and
proposed
uses
of
glufosinate­
ammonium
will
utilize
at
most
3.2%
of
the
chronic
population
adjusted
dose
for
the
U.
S.
population.
The
actual
exposure
is
likely
to
be
significantly
less
than
predicted
by
this
analysis
as
data
and
models
that
are
more
realistic
are
developed.
Exposures
below
100%
of
the
PAD
are
generally
assumed
to
be
of
no
concern
because
the
PAD
represents
the
level
at
or
below
which
daily
aggregate
exposure
over
a
lifetime
will
not
pose
appreciable
risk
to
human
health.
The
acute
population
of
concern,
female
13+
utilizes
13%
of
the
aPAD.
This
is
a
Tier
I
highly
conservative
assessment
and
actual
exposure
is
likely
to
be
far
less.
DWLOCs
based
on
dietary
exposures
are
greater
than
the
conservative
estimated
levels,
and
would
be
expected
to
be
well
below
the
100%
level
of
the
reference
dose,
if
they
occur
at
all.
EPA
has
concluded
that
it
is
not
appropriate
to
aggregate
non­
dietary
exposures
with
dietary
exposures
in
a
risk
assessment
because
the
toxicity
end­
points
are
different.
Therefore,
there
is
a
reasonable
certainty
that
no
harm
will
occur
to
the
U.
S.
population
from
aggregate
exposure
(
food,
drinking
water
and
nonresidential)
to
residues
of
glufosinate­
ammonium
and
metabolites.
2.
Infants
and
children.
The
toxicological
data
base
is
sufficient
for
evaluating
prenatal
and
postnatal
toxicity
for
glufosinate­
ammonium.
There
are
no
prenatal
or
postnatal
susceptibility
concerns
for
infants
and
children,
based
on
the
results
of
the
rat
and
rabbit
developmental
toxicity
studies
and
the
2
 
generation
reproduction
study.
Based
on
clinical
signs
of
neurological
toxicity
in
short
and
intermediate
dermal
toxicity
studies
with
rats,
EPA
has
determined
that
an
added
FQPA
safety
factor
of
3x
is
appropriate
of
assessing
the
risk
of
glufosinate­
ammonium
derived
residues
in
crop
commodities.
Using
the
conservative
assumptions
described
in
the
exposure
section
above,
the
percent
of
the
chronic
population
adjusted
dose
that
will
be
used
for
exposure
to
residues
of
glufosinateammonium
in
food
for
children
1
 
2
(
the
most
highly
exposed
sub­
group)
is
12%.
Infants
utilize
11.6%
of
the
chronic
PAD.
As
in
the
adult
situation,
DWLOCs
are
higher
than
the
worst
case
EDWC
and
are
expected
to
use
well
below
100%
of
the
PAD,
if
they
occur
at
all.
Therefore,
there
is
a
reasonable
certainty
that
no
harm
will
occur
to
infants
and
children
from
aggregate
exposure
to
residues
of
glufosinateammonium

F.
International
Tolerances
Maximum
residue
limits
for
glufosinate­
ammonium
and
metabolites
in
or
on
rice
commodities
have
not
been
established
by
the
Codex
Alimentarius
Commission.

[
FR
Doc.
03
 
20897
Filed
8
 
14
 
03;
8:
45
am]

BILLING
CODE
6560
 
50
 
S
ENVIRONMENTAL
PROTECTION
AGENCY
[
OPPT
 
2003
 
0050;
FRL
 
7323
 
6]

Certain
New
Chemicals;
Receipt
and
Status
Information
AGENCY:
Environmental
Protection
Agency
(
EPA).
ACTION:
Notice.

SUMMARY:
Section
5
of
the
Toxic
Substances
Control
Act
(
TSCA)
requires
any
person
who
intends
to
manufacture
(
defined
by
statute
to
include
import)
a
new
chemical
(
i.
e.,
a
chemical
not
on
the
TSCA
Inventory)
to
notify
EPA
and
comply
with
the
statutory
provisions
pertaining
to
the
manufacture
of
new
chemicals.
Under
sections
5(
d)(
2)
and
5(
d)(
3)
of
TSCA,
EPA
is
required
to
publish
a
notice
of
receipt
of
a
premanufacture
notice
(
PMN)
or
an
application
for
a
test
marketing
exemption
(
TME),
and
to
publish
periodic
status
reports
on
the
chemicals
under
review
and
the
receipt
of
notices
of
commencement
to
manufacture
those
chemicals.
This
status
report,
which
covers
the
period
from
July
14,
2003
to
July
31,
2003,
consists
of
the
PMNs
and
TME,
both
pending
or
expired,
and
the
notices
of
commencement
to
manufacture
a
new
chemical
that
the
Agency
has
received
under
TSCA
section
5
during
this
time
period.
DATES:
Comments
identified
by
the
docket
ID
number
OPPT
 
2003
 
0050
and
the
specific
PMN
number
or
TME
number,
must
be
received
on
or
before
September
15,
2003.
ADDRESSES:
Comments
may
be
submitted
electronically,
by
mail,
or
through
hand
delivery/
courier.
Follow
the
detailed
instructions
as
provided
in
Unit
I.
of
the
SUPPLEMENTARY
INFORMATION.

FOR
FURTHER
INFORMATION
CONTACT:
Barbara
Cunningham,
Director,
Environmental
Assistance
Division,
Office
of
Pollution
Prevention
and
Toxics
(
7408M),
Environmental
Protection
Agency,
1200
Pennsylvania
Ave.,
NW.,
Washington,
DC
20460
 
0001;
telephone
number:
(
202)
554
 
1404;
e­
mail
address:
TSCAHotline
epa.
gov.

SUPPLEMENTARY
INFORMATION:

I.
General
Information
A.
Does
this
Action
Apply
to
Me?

This
action
is
directed
to
the
public
in
general.
As
such,
the
Agency
has
not
attempted
to
describe
the
specific
entities
that
this
action
may
apply
to.
Although
others
may
be
affected,
this
action
applies
directly
to
the
submitter
of
the
premanufacture
notices
addressed
in
the
action.
If
you
have
any
questions
regarding
the
applicability
of
this
action
to
a
particular
entity,
consult
the
person
listed
under
FOR
FURTHER
INFORMATION
CONTACT.

B.
How
Can
I
Get
Copies
of
This
Document
and
Other
Related
Information?

1.
Docket.
EPA
has
established
an
official
public
docket
for
this
action
under
docket
identification
(
ID)
number
OPPT
 
2003
 
0050.
The
official
public
docket
consists
of
the
documents
specifically
referenced
in
this
action,
any
public
comments
received,
and
other
information
related
to
this
action.
Although
a
part
of
the
official
docket,
the
public
docket
does
not
include
Confidential
Business
Information
(
CBI)
or
other
information
whose
disclosure
is
restricted
by
statute.
The
official
public
docket
is
the
collection
of
materials
that
is
available
for
public
viewing
at
the
EPA
Docket
Center,
Rm.
B102­
Reading
Room,
EPA
West,
1301
Constitution
Ave.,
NW.,
Washington,
DC.
The
EPA
Docket
Center
is
open
from
8:
30
a.
m.
to
4:
30
p.
m.,
Monday
through
Friday,
excluding
legal
holidays.
The
EPA
Docket
Center
Reading
Room
telephone
number
is
(
202)
566
 
1744
and
the
telephone
number
for
the
OPPT
Docket,
which
is
located
in
EPA
Docket
Center,
is
(
202)
566
 
0280.

VerDate
jul<
14>
2003
16:
08
Aug
14,
2003
Jkt
200001
PO
00000
Frm
00038
Fmt
4703
Sfmt
4703
E:\
FR\
FM\
15AUN1.
SGM
15AUN1
